Document is current

Article History

Accepted: 2 June 2025

First Online: 21 June 2025

Declarations

:

: Open Access funding enabled and organized by CAUL and its Member Institutions. ACH is supported by a Rebecca L Cooper Al and Val Rosenstrauss Fellowship (GNT:F2021894). This study was funded by a grant to ACH from the Australian Office of Road Safety as part of the Road Safety Innovation Fund initiative (RSIF2-51). The sponsors provided funding for the study only. The study treatments were provided by CANN group Ltd. (Melbourne, Australia).

: AN, BM, BA, LAD and ACH have no conflicts of interests to declare that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others).

: Swinburne University of Technology’s Human Research Ethics Committee (approval granted: 22/12/2022; Ref: 20236915-16331). This trial was performed in accordance with Good Clinical Practice guidelines and the ethical standards of the Declaration of Helsinki.

: Written informed consent was obtained prior screening and the enrolment of each participant with ongoing eligibility and consent re-confirmed prior to treatment administration at each testing session.

: Not applicable.

: Not applicable.

: Data supporting findings in this study are available within the list of tables presented.

: AN: Data collection, formal analysis, visualisation, writing—original draft, writing—review and editing. BM, BA: Data collection, data management, writing—reviewing and editing. LAD: Conceptualization, methodology/study design, writing—reviewing and editing, funding acquisition. ACH: Conceptualization, methodology/study design, writing—reviewing and editing, funding acquisition. All authors have read and approved the final version of this manuscript and agree to be accountable for the work.